SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : 10-Bagger MINIMUM Rise from July 1, 2005 until December 31,

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Tadsamillionaire10/28/2005 10:57:27 PM
  Read Replies (1) of 1694
 
AVN Coverage by Leerink Swann price target 12-16
finance.yahoo.com
from Briefing.com

08:53 AVN AVANIR Pharma started with an Outperform at Leerink Swann; valuation range $12-16 (2.83 )
Leerink Swann initiates AVN with an Outperform and 12-month valuation tgt of $12-$16. They think that with the potential for an FDA approved product by mid-2006, Phase III results in a major indication approximately six months later and a pipeline including two programs partnered with large-cap pharmaceutical companies, the shares represent an attractive opportunity for small-cap investors.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext